Xeris Biopharma Holdings (XERS) EBITDA Margin (QoQ) (2020 - 2026)
Xeris Biopharma Holdings (XERS) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.41 Bn | 1.30 Bn | 72.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,002.00 |
| Dec 31, 2025 | 1,050.00 |
| Sep 30, 2025 | 278.00 |
| Jun 30, 2025 | 1,140.00 |
| Mar 31, 2025 | -793.00 |
| Dec 31, 2024 | 2,655.00 |
| Sep 30, 2024 | -672.00 |
| Jun 30, 2024 | 1,802.00 |
| Mar 31, 2024 | -1,288.00 |
| Dec 31, 2023 | -1,200.00 |
| Sep 30, 2023 | 3,187.00 |
| Jun 30, 2023 | -205.00 |
| Mar 31, 2023 | 577.00 |
| Dec 31, 2022 | 1,741.00 |
| Sep 30, 2022 | 1,157.00 |
| Jun 30, 2022 | 5,697.00 |
| Mar 31, 2022 | 9,354.00 |
| Dec 31, 2021 | -503.00 |
| Sep 30, 2021 | 6,931.00 |
| Jun 30, 2021 | -8,528.00 |